Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$7.57|
|52 Week High||CA$7.37|
|52 Week Low||CA$13.69|
|1 Month Change||-3.81%|
|3 Month Change||-18.16%|
|1 Year Change||-35.68%|
|3 Year Change||12.99%|
|5 Year Change||n/a|
|Change since IPO||215.42%|
Recent News & Updates
Shareholders May Not Be So Generous With Viemed Healthcare, Inc.'s (TSE:VMD) CEO Compensation And Here's Why
Under the guidance of CEO Casey Hoyt, Viemed Healthcare, Inc. ( TSE:VMD ) has performed reasonably well recently. As...
Viemed Healthcare (TSE:VMD) Could Easily Take On More Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
|VMD||CA Healthcare||CA Market|
Return vs Industry: VMD underperformed the Canadian Healthcare industry which returned 21.1% over the past year.
Return vs Market: VMD underperformed the Canadian Market which returned 31.4% over the past year.
Stable Share Price: VMD is less volatile than 75% of Canadian stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: VMD's weekly volatility (4%) has been stable over the past year.
About the Company
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home.
Viemed Healthcare Fundamentals Summary
|VMD fundamental statistics|
Is VMD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|VMD income statement (TTM)|
|Cost of Revenue||US$46.47m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.28|
|Net Profit Margin||9.24%|
How did VMD perform over the long term?See historical performance and comparison
Is Viemed Healthcare undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: VMD (CA$7.57) is trading above our estimate of fair value (CA$5)
Significantly Below Fair Value: VMD is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: VMD is good value based on its PE Ratio (21.3x) compared to the Canadian Healthcare industry average (21.8x).
PE vs Market: VMD is poor value based on its PE Ratio (21.3x) compared to the Canadian market (12.8x).
Price to Earnings Growth Ratio
PEG Ratio: VMD is poor value based on its PEG Ratio (1.3x)
Price to Book Ratio
PB vs Industry: VMD is good value based on its PB Ratio (2.7x) compared to the CA Healthcare industry average (3x).
How is Viemed Healthcare forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VMD's forecast earnings growth (15.8% per year) is above the savings rate (1.5%).
Earnings vs Market: VMD's earnings (15.8% per year) are forecast to grow faster than the Canadian market (12.1% per year).
High Growth Earnings: VMD's earnings are forecast to grow, but not significantly.
Revenue vs Market: VMD's revenue (14.1% per year) is forecast to grow faster than the Canadian market (6.1% per year).
High Growth Revenue: VMD's revenue (14.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if VMD's Return on Equity is forecast to be high in 3 years time
How has Viemed Healthcare performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: VMD has high quality earnings.
Growing Profit Margin: VMD's current net profit margins (9.2%) are lower than last year (26.6%).
Past Earnings Growth Analysis
Earnings Trend: VMD's earnings have grown significantly by 37.7% per year over the past 5 years.
Accelerating Growth: VMD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: VMD had negative earnings growth (-61.5%) over the past year, making it difficult to compare to the Healthcare industry average (56.6%).
Return on Equity
High ROE: VMD's Return on Equity (12.9%) is considered low.
How is Viemed Healthcare's financial position?
Financial Position Analysis
Short Term Liabilities: VMD's short term assets ($47.0M) exceed its short term liabilities ($18.3M).
Long Term Liabilities: VMD's short term assets ($47.0M) exceed its long term liabilities ($6.4M).
Debt to Equity History and Analysis
Debt Level: VMD's debt to equity ratio (8.1%) is considered satisfactory.
Reducing Debt: VMD's debt to equity ratio has reduced from 9.6% to 8.1% over the past 5 years.
Debt Coverage: VMD's debt is well covered by operating cash flow (312.2%).
Interest Coverage: VMD's interest payments on its debt are well covered by EBIT (35.3x coverage).
What is Viemed Healthcare current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate VMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate VMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if VMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if VMD's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of VMD's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Casey Hoyt (44 yo)
Mr. Casey Hoyt has been Director of Viemed Healthcare, Inc. since December 14, 2016 and Chief Executive Officer since December 2017. Mr. Hoyt served as Chief Executive Officer of Patient Home Monitoring Co...
CEO Compensation Analysis
Compensation vs Market: Casey's total compensation ($USD2.22M) is above average for companies of similar size in the Canadian market ($USD515.51K).
Compensation vs Earnings: Casey's compensation has been consistent with company performance over the past year.
Experienced Management: VMD's management team is considered experienced (3.5 years average tenure).
Experienced Board: VMD's board of directors are considered experienced (3.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Viemed Healthcare, Inc.'s employee growth, exchange listings and data sources
- Name: Viemed Healthcare, Inc.
- Ticker: VMD
- Exchange: TSX
- Founded: 2006
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: CA$301.058m
- Shares outstanding: 39.77m
- Website: https://www.viemed.com
Number of Employees
- Viemed Healthcare, Inc.
- 625 East Kaliste Saloom Road
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/09/25 02:25|
|End of Day Share Price||2021/09/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.